Company Overview and News

 
Constellium: Overlooked High Moat Business In A Commodity Market

2018-04-03 seekingalpha
Constellium (CSTM) is a global leader in designing and manufacturing rolled and extruded aluminum products with over 22 facilities worldwide.
Upvote Downvote

 
Xperi started at outperform with $27 stock price target at RBC Capital

2018-03-05 marketwatch
Technically speaking, the major U.S. stock benchmarks are starting 2018 against a firmly-bullish bigger-picture backdrop. On a headline basis, each big three benchmark — the S&P 500, Dow industrials and Nasdaq Composite — has sustained the decisive late-2017 technical breakout, and remains within striking distance of yet another record high.
Upvote Downvote

 
BRIEF-Constellium NV Says ‍Announced Opening Of Automotive Structures Plant In San Luis Potosí, Mexico

2018-03-01 reuters
* CONSTELLIUM NV - ANNOUNCED OPENING OF AUTOMOTIVE STRUCTURES PLANT IN SAN LUIS POTOSÍ, MEXICO Source text for Eikon: Further company coverage:
Upvote Downvote

 
Surprisingly Good Numbers From Constellium Contrast Starkly With Alcoa's Poor Performance

2018-02-26 seekingalpha
Constellium continues to outperform Alcoa in the near-term, and potentially in the long-term as well, with global demand and tariff issues continuing to support pricing for both companies.
Upvote Downvote

 
Constellium's (CSTM) CEO Jean-Marc Germain on Q4 2017 Results - Earnings Call Transcript

2018-02-23 seekingalpha
Good morning and welcome to Constellium's Fourth Quarter and Full-Year 2017 Earnings Presentation. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded today, Thursday, February 22, 2018. I will now like to turn the call over to Ryan Wentling, Director of Investor Relations at Constellium.
Upvote Downvote

 
Constellium Holdco B.V. 2017 Q4 - Results - Earnings Call Slides

2018-02-23 seekingalpha
The following slide deck was published by Constellium Holdco B.V. in conjunction with their 2017 Q4 earnings call.
Upvote Downvote

 
Oaktree Specialty Lending upgraded to overweight from neutral at J.P. Morgan

2018-02-06 marketwatch
Prospect Capital's Fiscal Q2 2018 NII And NAV Projection (Impacts From Tax Cuts And Jobs Act)
Upvote Downvote

 
Alcoa Headwinds Vs. Constellium Tailwinds

2018-01-22 seekingalpha
The aluminum market has had a great 2017 with plenty of upside left for materials in 2018.
Upvote Downvote

 
Constellium - Bridging The Gap Until 2019 On Excellent Terms

2017-11-10 seekingalpha
Downside risk is mitigated for the company as it can now withstand a prolonged downturn in the market as it nears cash flow positive results.
Upvote Downvote

 
BRIEF-Constellium prices offering of ordinary shares

2017-11-01 reuters
* Constellium NV says ‍has priced a public offering of 25 million newly issued class a ordinary shares at $11 per share​ Source text for Eikon: Further company coverage:
Upvote Downvote

1
Constellium: Bull Thesis Gets Better And Better

2017-10-30 seekingalpha
Constellium NV's (CSTM) stock is reaching not only new 52-week highs, but highs the stock has not seen for the past couple of years. Raising guidance, while continuing to deleverage the overburdened company, as metal prices appreciate and auto body sales escalate, are resulting in an uptick in expectations for future performance that is being reflected in the company's rising stock price.
Upvote Downvote

1
Constellium: Aluminum Rally Gone Too Far?

2017-10-06 seekingalpha
The vast majority of the company's sales continue to be in low growth industries, and the focus for the next few years will continue to be on cost and efficiency.
Upvote Downvote

 
Aditya Birla’s acquisition bid may value Aleris Corp at $2.5 billion

2017-09-24 livemint
Mumbai: Billionaire Kumar Mangalam Birla’s Aditya Birla Group is readying a bid for aluminium maker Aleris Corp., according to two people directly aware of the development.
Upvote Downvote

 
Special Situation Ideas For The Week Of August 6, 2017

2017-08-08 seekingalpha
Those looking into some catalyst might want to ponder over these names for the week. I have done research on few of them, the other I have read online on Barron's and other publications.
Upvote Downvote

 
Why Constellium N.V.'s Shares Popped 19% Today

2017-08-04 fool
Founded in 1993 by brothers Tom and David Gardner, The Motley Fool helps millions of people attain financial freedom through our website, podcasts, books, newspaper column, radio show, and premium investing services.
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...